TLR3 — Toll-Like Receptor 3

TLR3 — Toll-Like Receptor 3

Introduction

Tlr3 — Toll Like Receptor 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@letsiou2019]
<span class="infobox-title">TLR3 Gene</span> [@zhang2018]
| Property | Value |
|----------|-------|
| Gene Symbol | TLR3 |
| Full Name | Toll-Like Receptor 3 |
| Chromosomal Location | 4q35 |
| NCBI Gene ID | 7098 |
| OMIM ID | 603029 |
| Ensembl ID | ENSG00000164342 |
| UniProt ID | Q9Y5Y9 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Viral Encephalitis, Neuroinflammation |
</div>

Overview

...

TLR3 — Toll-Like Receptor 3

Introduction

Tlr3 — Toll Like Receptor 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@letsiou2019]
<span class="infobox-title">TLR3 Gene</span> [@zhang2018]
| Property | Value |
|----------|-------|
| Gene Symbol | TLR3 |
| Full Name | Toll-Like Receptor 3 |
| Chromosomal Location | 4q35 |
| NCBI Gene ID | 7098 |
| OMIM ID | 603029 |
| Ensembl ID | ENSG00000164342 |
| UniProt ID | Q9Y5Y9 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Viral Encephalitis, Neuroinflammation |
</div>

Overview

TLR3 (Toll-Like Receptor 3) encodes a pattern recognition receptor that specifically recognizes double-stranded RNA (dsRNA), a viral replication intermediate. TLR3 is expressed in various cell types in the brain and plays a critical role in antiviral immune responses and has been implicated in neurodegenerative diseases.

Normal Function

TLR3 is expressed in [microglia](/cell-types/microglia-neuroinflammation), astrocytes, neurons, and oligodendrocytes. It functions as:

• Viral dsRNA sensor: Recognizes dsRNA from viral infections
• Innate immune activator: Triggers type I interferon (IFN-α/β) responses
• Cross-presentation enhancer: Promotes antigen presentation to CD8+ T cells
• Neuroprotective role: Can induce antiviral and anti-inflammatory responses

Signaling Pathways

TLR3 signals through:

• TRIF-dependent pathway: TRIF → TRAF3 → TBK1 → IRF3/IRF7 → Type I IFN
• [NF-κB](/entities/nf-kb) activation: Through RIP1 and TAK1
• AP-1 activation: Via MAPK pathways

Gene Structure

The TLR3 gene is located on chromosome 4q35 and consists of multiple exons encoding a 904-amino acid type I transmembrane protein with an extracellular leucine-rich repeat (LRR) domain.

Disease Associations

Alzheimer's Disease

• TLR3 may recognize viral dsRNA from herpesviruses implicated in AD
• Involved in antiviral immune responses that may cross-react with [Aβ](/proteins/amyloid-beta)
• Controversial role: both protective and pathogenic mechanisms proposed

Parkinson's Disease

• TLR3 activation may protect against viral triggers in PD
• Some studies show reduced TLR3 expression in PD brains
• Viral infection hypothesis of PD involves TLR3

Viral Encephalitis

• Critical for antiviral immunity in the brain
• Herpes simplex virus (HSV-1) recognition
• Potential therapeutic target for viral brain infections

Other Conditions

• Multiple Sclerosis: TLR3 variants may influence disease course
• Amyotrophic Lateral Sclerosis: Altered TLR3 responses reported

Expression Pattern

TLR3 is expressed in:

• [Neurons](/entities/neurons) (particularly cortical and hippocampal)
• [Astrocytes](/entities/astrocytes)
• [Microglia](/entities/microglia)
• [Oligodendrocytes](/cell-types/oligodendrocytes)

Expression is inducible and increases during viral infections.

Therapeutic Targeting

| Strategy | Approach | Status |
|----------|----------|--------|
| TLR3 Agonists | Poly(I:C) as adjuvant | Research |
| TLR3 Antagonists | Blocking viral-induced inflammation | Preclinical |
| Antiviral Therapy | Targeting HSV-1 reactivation | Clinical |

Research Directions

• Understanding TLR3's role in AD viral hypothesis
• Developing selective TLR3 modulators
• Biomarker potential: TLR3 expression as infection marker

Background

The study of Tlr3 — Toll Like Receptor 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• TLR2 Gene — Related toll-like receptor
• [TLR4 Gene — Related toll-like receptor](/genes/tlr4)
• [Neuroinflammation — Inflammatory mechanisms](/content/mechanisms)
• [Alzheimer's Disease — AD overview](/diseases/alzheimers-disease)

External Links

• [NCBI Gene: TLR3](https://www.ncbi.nlm.nih.gov/gene/7098)
• [UniProt: TLR3](https://www.uniprot.org/uniprot/Q9Y5Y9)
• [Ensembl: TLR3](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164342)

References

[Cameron JS, et al, Herpes simplex virus type 1 in brain and risk of Alzheimer's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17827059/))

[Letsiou E, et al, TLR3 deficiency in humans: Herpes simplex encephalitis, recurrent meningitis (2019)](https://pubmed.ncbi.nlm.nih.gov/30898568/))

[Zhang Y, et al, TLR3 polymorphisms and neurodegenerative diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/29787875/))

Pathway Diagram

The following diagram shows the key molecular relationships involving TLR3 — Toll-Like Receptor 3 discovered through SciDEX knowledge graph analysis: